Navigation Links
Genoptix Reports Strong Growth for the First Quarter of 2009
Date:4/30/2009

reasing from 2.1% for the first quarter of 2008. In the first quarter of 2009, the Company operated as a fully taxed corporation, following the recognition of the remaining available deferred tax assets in the last half of 2008.

Net income was $5.9 million for the first quarter of 2009, compared to net income of $5.0 million for the first quarter of 2008. Diluted earnings per share, or EPS, for the first quarter of 2009 was $0.33 based on 17.8 million weighted average common shares outstanding. This compares to EPS of $0.29 for the first quarter of 2008, which would have been reduced by approximately $0.13 if taxed at the current rate.

As of March 31, 2009, the Company's total cash, cash equivalents and investment securities were $111.5 million. For the first quarter of 2009, cash generated from operations was $5.3 million, while purchases of capital equipment for the same period totaled $1.6 million. The first quarter of 2009 ended with bad debt expense at approximately 3% of total revenues and days sales outstanding of 67 days, down from 71 days in the first quarter of 2008.

"We have continued to develop and strengthen the organization in the first quarter, moving forward with our growth initiatives and our hiring plan. In the first quarter, our sales team grew to 62 field representatives, up from 55 at the end of 2008 and moving us closer to our goal of 85 representatives by the end of 2009," said Sam Riccitelli, Genoptix EVP and COO. "We also increased the size of the Cartesian Medical Group, bringing the total number of hematopathologists to 26 and keeping us on track toward our goal of housing approximately 37 physicians by year-end."

Revised 2009 Performance Outlook

For the full-year 2009, Genoptix expects revenues of between $170 to $175 million, up from previous expectations of approximately $170 million, with gross margins in the high-fiftieth percentile.

<
'/>"/>
SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Genoptix, Inc. Announces Pricing for Initial Public Offering
2. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
3. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
4. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
5. Genoptix Announces Pricing of Secondary Public Offering
6. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
7. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
8. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
9. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
10. Genoptix Reports Strong Financial Results for First Quarter 2008
11. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... ... Law Group is pleased to announce the relocation of the firm's headquarters to 225 ... a state of the art building, located with easy access to New York City's ... "We are pleased to service our clients from such a premier location and we ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... SC&H Group, ... Service, which aims to give back to the community through company-wide volunteering efforts. , ... SC&H Group dedicate the day to assisting those in need throughout Baltimore and Washington ...
(Date:7/7/2015)... ... , ... At the end of June Pacific Prime Renewals team in Hong Kong announced ... by the Renewals Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the ... explained, “We send anything between 300 and 600 pieces of paper per month. Not to ...
(Date:7/7/2015)... ... 07, 2015 , ... Summer is a great time to get outside and ... sharing some safety tips. , Jean Tapley, senior wellness coordinator at Amica, suggests the ... , Start slowly. Going from no activity to several hours of activity ...
(Date:7/7/2015)... ... ... Healthpointe is proud to announce the addition of Dr. Pedro S. Alupay to ... evaluating and treating patients with orthopedic complaints, such as lumbar back pain or cervical ... Biology from the University of the East, Manila, Dr. Alupay earned his Doctorate of ...
Breaking Medicine News(10 mins):Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... ... obscure Georgia Law that forces insurance companies to cover Sedation Dentistry for Georgia Dental Patients ... over 20 years and he just found out about the law so the general public ... ...
... SIAL ) today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule ... ... , , ... ...
... ... a company that builds open source platforms and develops advanced research ... Health (NIH) totaling more than $600,000 to focus research efforts on ... the research is to work towards an interactive simulator that replicates ...
... The presence of plaque on an abdominal CT scan is ... to a Henry Ford Hospital study. Researchers found that ... artery disease when the CT scan showed very high levels ... of the abdominal aortic calcium also increased their risk of ...
... Diovan, Starlix also had limited or no effect in ... March 14 (HealthDay News) -- Hopes that two available ... causes in overweight people with poor sugar metabolism have ... trial involved two drugs prescribed for other reasons -- ...
... ... named to the editorial board of Otology/Neurotology. , ... (Vocus) March 13, 2010 -- Jed ... editorial board of Otology/Neurotology. The official journal of the American Otological Society and ...
Cached Medicine News:Health News:Georgia Dentist Uncovers Obscure Law That Helps Dental Patients With Severe Anxiety 2Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 2Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 3Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 4Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 5Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 2Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 3Health News:Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes 2Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 2Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 3Health News:Summit Medical Group Physician Named to Medical Journal Editorial Board 2Health News:Summit Medical Group Physician Named to Medical Journal Editorial Board 3
(Date:7/7/2015)... , June 30, 2015 ... the addition of the "Deciphering Global Major ... report to their offering. It has ... have been involved in a series of challenges ... has resulted in significant overcapacities in small molecule ...
(Date:7/7/2015)... , July 7, 2015   Decision ... and differences in dialysis patient management in the ... information submitted by U.S. and EU5 nephrologists from ... phosphate binders are the most commonly used renal ... IV iron differs considerably between the two regions.      ...
(Date:7/7/2015)... and BANGALORE , July 7, 2015 ... technology provider of innovative clinical trial data management solutions, ... Research Reports) recent publication named " EDC and eCOA ... ". ISR Reports is one of the leading providers ... this report evaluated 22 EDC and eCOA / ePRO ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: ... of vaccines against HPV, anthrax and plague ... The,studies were conducted by the Fraunhofer USA ... Organization led by Dr.,Vidadi Yusibov, through which ...
... Profile and Excellent,Pharmacokinetic Properties -, RESEARCH TRIANGLE PARK, ... a clinical stage company developing and,commercializing innovative treatments ... top-line results from a Phase I,clinical trial of ... and anxiety. In this study, Tyrima was safe ...
Cached Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Spoon end periosteal, polished finish, designed for large mucoperiosteal flaps....
Medicine Products: